Adam Kroetsch is a Research Director at the Duke-Robert J. Margolis, MD, Center for Health Policy in Washington, DC, where he oversees the Center’s portfolio of research on biomedical innovation and regulatory science, including research on pharmaceutical quality and drug shortages. Before joining the Duke-Margolis Center, he worked at the FDA for over a decade, including serving as the deputy director of the FDA Drug Center’s Office of Program and Strategic Analysis, supporting the agency’s efforts to address drug shortages through policy analysis, modeling, and analytics. He received his Master’s in Public Policy and Management from Carnegie Mellon University and his Bachelor of Science in Policy Analysis and Management from Cornell University.